Acute ischemic cholecystitis after transarterial chemoembolization with drug-eluting beads

Abstract Transarterial chemoembolization (TACE) is a widely used treatment choice for hepatocellular cancer. DC Bead microspheres are a new embolic material for TACE that doxorubicin can be loaded to. The tumor response rate of this well-tolerated treatment was changed between 60% and 81.8%. We repo...

Full description

Saved in:
Bibliographic Details
Published in:Clinical imaging 2012-11, Vol.36 (6), p.861-864
Main Authors: Karaman, Bülent, Battal, Bilal, Ören, Nisa Cem, Üstünsöz, Bahri, Yağci, Gökhan
Format: Article
Language:English
Subjects:
Antineoplastic Agents - adverse effects
Beads
Cancer
Chemoembolization, Therapeutic - adverse effects
Cholecystitis
Cholecystitis, Acute - chemically induced
Cholecystitis, Acute - diagnostic imaging
Cholecystography
Delayed-Action Preparations - adverse effects
Direct current
Doxorubicin
Doxorubicin - adverse effects
Drug-eluting beads
Gallbladder
Gallbladder - blood supply
Gallbladder - drug effects
Gallbladder diseases
Hemostatics - adverse effects
Hepatocellular cancer
Humans
Imaging
Male
Medical treatment
Microspheres
Mortality
Pain
Polyvinyl alcohol
Radiology
Risk
Segments
Transarterial chemotherapy
Tumors
Veins & arteries
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Transarterial chemoembolization (TACE) is a widely used treatment choice for hepatocellular cancer. DC Bead microspheres are a new embolic material for TACE that doxorubicin can be loaded to. The tumor response rate of this well-tolerated treatment was changed between 60% and 81.8%. We report a case of ischemic cholecystitis after TACE with drug-eluting beads (DEB) that required cholecystectomy. The possibility of cholecystitis is always remembered during TACE-DEB for tumors in segment IV and/or V. Although selective catheterization is related with a lower risk for ischemic cholecystitis, the anatomic and vascular variability in patients with malignancy may lead to some unexpected conditions.
ISSN:0899-7071
1873-4499
DOI:10.1016/j.clinimag.2012.01.030